The Gross Margin of Corline Biomedical AB (CLBIO.ST) is 137.50%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 137.50% |
| 2023-12-31 | 113.38% |
| 2022-12-31 | 96.50% |
| 2021-12-31 | 128.89% |
| 2020-12-31 | 279.22% |
| 2019-12-31 | 671.71% |
| 2018-12-31 | 417.72% |
| 2017-12-31 | 105.17% |
| 2016-12-31 | 786.69% |
| 2015-12-31 | 308.62% |